References
- Lund L. Anticonvulsant effect of diphenylhydantoin relative to plasma level. Arch. Neurol. 1974; 31: 289
- Kutt H. Some causes of ineffectiveness of DPH. Arch. Neurol. 1966; 14: 489
- Atkinson A. J., Shaw J. M. Pharmacokinetic study of a patient with diphenylhydantoin toxicity. Clin. Pharmacol. Therap. 1973; 14: 521
- Bochner F., et al. Effect of dosage increments on blood phenytoin concentrations. J. Neurol., Neurosurg., Psychiat. 1972; 35: 873
- Reidenberg M. M., et al. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. New Engl. J. Med 1971; 285: 264
- Letteri J. M., et al. Diphenylhydantoin metabolism in uremia. New Engl. J. Med. 1971; 285: 648
- Odar-Cederlöf I., Borga O. Kinetics of diphenylhydantoin in uremic patients: Consequences of decreased plasma protein binding. Europ. J. Pharmacol. 1974; 7: 31
- Martin E., Gambertoglio J., Adler D., et al. Removal of phenytoin by hemodialysis in uremic patients. JAMA 1977; 238: 1750